ARCHIVES

Two Conflicting Studies Presented at ASCO 2013, FDA Called Upon To Sort Through The Data

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

FDA Approves Rituxan For CLL

February 19, 2010

Correction: Appropriations Reports Included Language of Minorities and Underserved

October 15, 1999

Also in This 8-page Issue: President Bush Nominates EPA Administrator Michael Leavitt for HHS Secretary.

January 7, 2005

Dendritic Cell Vaccine Increases PFS in Phase II Clinical Trial

December 27, 2013

Broder Sworn In, Cites Three ‘Teachers’ – Gallo, Waldermann, DeVita

January 27, 1989

Statistical Models Determine Stem-Cell Transplant Effectiveness

July 26, 2013